Rohit Kumar | James Cook Hospital, United Kingdom
Abstract
CMV is the most frequent congenital infection and has a UK incidence of around 3-4/1000 live births. Around 10-15% of these infants will be symptomatic, of whom up to 90% will develop long term sequelae usually in the form of sensorineural hearing loss, visual impairment, or developmental delay. Some 13% of asymptomatic infants also develop long term problems. Despite such morbidity, decisions of whom to treat, and for how long, remain controversial. Audience Take Away Objectives of session: Whilst there is some support for treating infants with CNS symptoms, there is a paucity of high-level evidence for treating infants with other organ involvement In addition, the adverse effects of treatment are not inconsiderable Thus the talk will aim to address these dilemmas and help the participants develop an evidence-based management approach
